SE435280B - Sett att framstella nya 0-(3-amino-2-hydroxipropyl)-amidoximderivat - Google Patents

Sett att framstella nya 0-(3-amino-2-hydroxipropyl)-amidoximderivat

Info

Publication number
SE435280B
SE435280B SE7709482A SE7709482A SE435280B SE 435280 B SE435280 B SE 435280B SE 7709482 A SE7709482 A SE 7709482A SE 7709482 A SE7709482 A SE 7709482A SE 435280 B SE435280 B SE 435280B
Authority
SE
Sweden
Prior art keywords
hydroxypropyl
amino
make new
amidoxime derivatives
amidoxime
Prior art date
Application number
SE7709482A
Other languages
English (en)
Other versions
SE7709482L (sv
Inventor
K Takacs
P Literati
I Kiss
A Simay
M Szentivanyi
S Virag
K Farago
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of SE7709482L publication Critical patent/SE7709482L/sv
Publication of SE435280B publication Critical patent/SE435280B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/12Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines
    • C07C259/14Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines having carbon atoms of hydroxamidine groups bound to hydrogen atoms or to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Quinoline Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Pyrrole Compounds (AREA)
SE7709482A 1976-08-27 1977-08-23 Sett att framstella nya 0-(3-amino-2-hydroxipropyl)-amidoximderivat SE435280B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU76CI1682A HU177578B (en) 1976-08-27 1976-08-27 Process for preparing new 0-/3-amino-2-hydroxy-propyl/-amidoxime derivatives

Publications (2)

Publication Number Publication Date
SE7709482L SE7709482L (sv) 1978-02-28
SE435280B true SE435280B (sv) 1984-09-17

Family

ID=10994625

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7709482A SE435280B (sv) 1976-08-27 1977-08-23 Sett att framstella nya 0-(3-amino-2-hydroxipropyl)-amidoximderivat

Country Status (23)

Country Link
JP (1) JPS5350131A (sv)
AT (1) AT355554B (sv)
AU (1) AU521432B2 (sv)
BE (1) BE858134A (sv)
CA (1) CA1077506A (sv)
CH (1) CH630344A5 (sv)
CS (1) CS204008B2 (sv)
DD (1) DD132433A5 (sv)
DE (1) DE2738589A1 (sv)
DK (1) DK150196C (sv)
ES (1) ES462346A1 (sv)
FI (1) FI68396C (sv)
FR (1) FR2362845A1 (sv)
GB (1) GB1582029A (sv)
GR (1) GR63623B (sv)
HU (1) HU177578B (sv)
IL (1) IL52804A (sv)
NL (1) NL187478C (sv)
NO (1) NO144793C (sv)
PL (1) PL107628B1 (sv)
SE (1) SE435280B (sv)
SU (1) SU730296A3 (sv)
YU (2) YU202377A (sv)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4849522A (en) * 1983-11-03 1989-07-18 Merrell Dow Pharmaceuticals Novel alkoxyimino ether derivatives of 5-acyl-2(1H)-pyridinones
US5212314A (en) * 1983-11-03 1993-05-18 Merrell Dow Pharmaceuticals Inc. Alkoxyimino ether derivatives of 5-acyl-2(1H)-pyridinones
ZA848428B (en) * 1983-11-03 1985-06-26 Merrell Pharma Inc Novel alkoxyimino ether derivatives of 5-acyl-2(1h)-pyridiones
JPH01169445A (ja) * 1987-12-25 1989-07-04 Fuji Photo Film Co Ltd 焦点距離切換えカメラ
HU207988B (en) * 1988-10-20 1993-07-28 Biorex Kutato Fejlesztoe Kft Process for producing halogenides of o-/3-amino-2-hydroxy-propyl/hydroximic acid and pharmaceutical compositions containing them as active components
HUT54347A (en) * 1989-01-10 1991-02-28 Chinoin Gyogyszer Es Vegyeszet Improved process for producing amidoximes
HU222994B1 (hu) 1995-11-02 2004-01-28 BIOREX Kutató és Fejlesztő Rt. Hidroxilaminszármazékok és azok alkalmazása sejtek molekuláris chaperon-termelésének fokozására alkalmas gyógyszerkészítmények előállítására
HUT78139A (hu) * 1995-12-22 2000-11-28 BIOREX Kutató és Fejlesztő Rt. Készítmény, különösen a bőr öregedési folyamatainak mérséklésére
IL139470A0 (en) 1998-05-11 2001-11-25 Takeda Chemical Industries Ltd Oxyiminoalkanoic acid derivatives
AU5296799A (en) * 1998-08-03 2000-02-28 N-Gene Kutato Kft. Pharmaceutical compositions against autoimmune diseases
PL371251A1 (en) 2002-01-11 2005-06-13 Biorex Kutato Es Fejlesztö Rt. Carboxamidine derivatives and their use in the treatment of vascular diseases
HUP0303584A3 (en) 2003-10-30 2009-12-28 Cytrx Corp Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases
EP4247792A1 (en) 2020-11-19 2023-09-27 Zevra Denmark A/S Processes for preparing arimoclomol citrate and intermediates thereof

Also Published As

Publication number Publication date
CH630344A5 (en) 1982-06-15
FR2362845A1 (fr) 1978-03-24
FR2362845B1 (sv) 1981-01-09
IL52804A (en) 1981-06-29
FI68396C (fi) 1985-09-10
JPS6216942B2 (sv) 1987-04-15
SE7709482L (sv) 1978-02-28
CS204008B2 (en) 1981-03-31
DE2738589A1 (de) 1978-03-02
NO144793C (no) 1981-11-11
JPS5350131A (en) 1978-05-08
DD132433A5 (de) 1978-09-27
PL107628B1 (pl) 1980-02-29
AU521432B2 (en) 1982-04-01
HU177578B (en) 1981-11-28
FI772551A (fi) 1978-02-28
SU730296A3 (ru) 1980-04-25
YU202377A (en) 1983-12-31
DK150196C (da) 1987-07-06
YU237782A (en) 1983-12-31
FI68396B (fi) 1985-05-31
BE858134A (fr) 1977-12-16
ATA605477A (de) 1979-08-15
NO144793B (no) 1981-08-03
DK150196B (da) 1987-01-05
DK379777A (da) 1978-02-28
ES462346A1 (es) 1978-06-16
GB1582029A (en) 1980-12-31
NL187478C (nl) 1991-10-16
AU2825477A (en) 1979-03-01
AT355554B (de) 1980-03-10
NO772958L (no) 1978-02-28
GR63623B (en) 1979-11-27
IL52804A0 (en) 1977-10-31
CA1077506A (en) 1980-05-13
NL7709276A (nl) 1978-03-01

Similar Documents

Publication Publication Date Title
SE441528B (sv) Sett att framstella nya 3-kinolin-karboxylsyraderivat
SE436425B (sv) Sett att framstella nya spirolaktoner
SE431935B (sv) Sett att framstella drageer
SE440779B (sv) Sett att framstella androstan-17-on-derivat
SE7606280L (sv) Sett att framstella etrar
SE435928B (sv) Sett att framstella nya 3-aryl-oxazolidin-2-oner
SE7607152L (sv) Sett att framstella nya 2-piperidinoalkyl-1,4-bensdioxaner
SE441042B (sv) Sett att pavisa rheumatoida faktorer
SE432256B (sv) Sett att framstella cellulosaalkyletrar
SE427111B (sv) Sett att framstella pilokarpiniumsalter
SE435280B (sv) Sett att framstella nya 0-(3-amino-2-hydroxipropyl)-amidoximderivat
SE431087B (sv) Sett att framstella nya omega-aminokarboxylsyraamider
SE430687B (sv) Sett att framstella hexanitrostilben
SE7602729L (sv) Sett att framstella nya indolylalkylpiperidiner
SE436037B (sv) Sett att framstella nya 11-desoxi-prostaglandin-f?712-derivat
SE420732B (sv) Sett att framstella 4-gonen-3-oner
SE434842B (sv) Sett att framstella nya 7-amino-tiazolyl-acetamido-cefalosporansyraderivat
SE424991B (sv) Sett att framstella nya 5-fenyl-oxazolidinoner
SE417895B (sv) Tandvardsmedel for att motverka dental karies
SE7705986L (sv) Sett att framstella nya aryltrifluoretyaminer
SE434397B (sv) Sett att framstella bens-acyl-bensimidazol-2-derivat
SE430156B (sv) Sett att framstella 2-subst-1-(omega-aminoalkoxi)-bensener
SE425390B (sv) Sett att framstella nya 11-oxo-prostaglandinderivat
SE8300445D0 (sv) Sett att framstella nya aminoalkoxibensofuraner
SE433213B (sv) Sett att framstella 2 -fenyl-3-amino-benso/b/tiofenderivat

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7709482-9

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7709482-9

Format of ref document f/p: F